By disseminating research results through a wide range of media such as patents, academic papers, and conference presentations, we are also contributing to the development of this field.
One of the distinctive technologies that Supera Pharma has inherited from Takeda Pharmaceutical is the chiral technology that has been cultivated over many years in the process chemistry department. With the aim of developing manufacturing methods for chiral new drugs, we have engaged in research and development of asymmetric metal catalyst reactions centered around asymmetric hydrogenation reactions, chiral column technology for analysis and separation purposes, enzyme technology with high enantioselectivity potential, and diastereomer salt technology essential for establishing manufacturing processes. Our company will provide solutions tailored to customer needs by utilizing these technologies individually or in combination. *For detailed information about the columns, please refer to the related links. For more information, feel free to contact us.
Inquire About This Product
basic information
*You can view the detailed content of the column through the related link. For more information, please feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
The detailed content of the column can be viewed through the related link. For more information, please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.
